BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16778825)

  • 21. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells.
    Falini B; Fizzotti M; Pucciarini A; Bigerna B; Marafioti T; Gambacorta M; Pacini R; Alunni C; Natali-Tanci L; Ugolini B; Sebastiani C; Cattoretti G; Pileri S; Dalla-Favera R; Stein H
    Blood; 2000 Mar; 95(6):2084-92. PubMed ID: 10706878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
    Lucioni M; Berti E; Arcaini L; Croci GA; Maffi A; Klersy C; Goteri G; Tomasini C; Quaglino P; Riboni R; Arra M; Dallera E; Grandi V; Alaibac M; Ramponi A; Rattotti S; Cabras MG; Franceschetti S; Fraternali-Orcioni G; Zerbinati N; Onida F; Ascani S; Fierro MT; Rupoli S; Gambacorta M; Zinzani PL; Pimpinelli N; Santucci M; Paulli M
    Cancer Med; 2016 Oct; 5(10):2740-2755. PubMed ID: 27665744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL-6 protein is expressed in germinal-center B cells.
    Cattoretti G; Chang CC; Cechova K; Zhang J; Ye BH; Falini B; Louie DC; Offit K; Chaganti RS; Dalla-Favera R
    Blood; 1995 Jul; 86(1):45-53. PubMed ID: 7795255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin.
    Carbone A; Gloghini A; Libra M; Gasparotto D; Navolanic PM; Spina M; Tirelli U
    Mod Pathol; 2006 Feb; 19(2):299-306. PubMed ID: 16400323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.
    Raible MD; Hsi ED; Alkan S
    Am J Clin Pathol; 1999 Jul; 112(1):101-7. PubMed ID: 10396291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of FOXP1 is required during germinal center B-cell function.
    Sagardoy A; Martinez-Ferrandis JI; Roa S; Bunting KL; Aznar MA; Elemento O; Shaknovich R; Fontán L; Fresquet V; Perez-Roger I; Robles EF; De Smedt L; Sagaert X; Melnick A; Martinez-Climent JA
    Blood; 2013 May; 121(21):4311-20. PubMed ID: 23580662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas.
    Greiner A; Müller KB; Hess J; Pfeffer K; Müller-Hermelink HK; Wirth T
    Am J Pathol; 2000 Feb; 156(2):501-7. PubMed ID: 10666379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes.
    Naresh KN
    Haematologica; 2007 Feb; 92(2):267-8. PubMed ID: 17296585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications.
    Balague O; Mozos A; Martinez D; Hernandez L; Colomo L; Mate JL; Teruya-Feldstein J; Lin O; Campo E; Lopez-Guillermo A; Martinez A
    Am J Pathol; 2009 Jun; 174(6):2337-46. PubMed ID: 19389935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focal follicular features in tonsillar diffuse large B-cell lymphomas: follicular lymphoma with diffuse areas or follicular colonization.
    Ree HJ; Kikuchi M; Lee SS; Ohshima K; Yang WI; Ko YH; Cho EY; Rhee JC
    Hum Pathol; 2002 Jul; 33(7):732-40. PubMed ID: 12196925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: A study of 18 cases.
    Al-Abbadi MA; Hattab EM; Tarawneh MS; Amr SS; Orazi A; Ulbright TM
    Mod Pathol; 2006 Dec; 19(12):1521-7. PubMed ID: 16998463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy.
    Uranishi M; Iida S; Sanda T; Ishida T; Tajima E; Ito M; Komatsu H; Inagaki H; Ueda R
    Leukemia; 2005 Aug; 19(8):1471-8. PubMed ID: 15959530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.
    Richards KL; Motsinger-Reif AA; Chen HW; Fedoriw Y; Fan C; Nielsen DM; Small GW; Thomas R; Smith C; Dave SS; Perou CM; Breen M; Borst LB; Suter SE
    Cancer Res; 2013 Aug; 73(16):5029-39. PubMed ID: 23783577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
    Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G
    Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.